These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1574592)

  • 21. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local control of T3 carcinomas after accelerated fractionation: a look at the "gap".
    Wang CC; Efird J; Nakfoor B; Martins P
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):439-41. PubMed ID: 8655365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does treatment interruption and baseline hemoglobin affect overall survival in early laryngeal cancer treated with radical radiotherapy? 10 years follow up.
    Eldeeb H; Abdel-Khalk S
    J BUON; 2014; 19(1):124-9. PubMed ID: 24659653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of radical radiotherapy alone for functional preservation of larynx in laryngeal carcinoma: a retrospective analysis.
    Bhattacharyya T; Ghoshal S; Dhanireddy B; Kumar R; Sharma SC
    Indian J Cancer; 2014; 51(1):10-4. PubMed ID: 24947088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers.
    Robertson C; Robertson AG; Hendry JH; Roberts SA; Slevin NJ; Duncan WB; MacDougall RH; Kerr GR; O'Sullivan B; Keane TJ
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):319-29. PubMed ID: 9457816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of postradiotherapy neck dissection in supraglottic carcinoma.
    Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy.
    Cho EI; Sasaki CT; Haffty BG
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1135-40. PubMed ID: 15001255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Timing and duration of postoperative radiotherapy in patients with laryngeal cancer].
    Milecki P; Kruk-Zagajewska A; Stryczyńska G
    Otolaryngol Pol; 2002; 56(3):307-11. PubMed ID: 12162018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis.
    Robertson AG; Robertson C; Perone C; Clarke K; Dewar J; Elia MH; Hurman D; MacDougall RH; Yosef HM
    Radiother Oncol; 1998 Aug; 48(2):165-73. PubMed ID: 9783888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation.
    Yoo SS; Carter D; Turner BC; Sasaki CT; Son YH; Wilson LD; Glazer PM; Haffty BG
    Int J Cancer; 2000 Feb; 90(1):22-8. PubMed ID: 10725854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagus.
    Kajanti M; Kaleta R; Kankaanranta L; Muhonen T; Holsti L
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1017-23. PubMed ID: 7607921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical radiotherapy for carcinoma of the larynx in the elderly: Functional and oncological outcomes from a tertiary cancer care center in India.
    Subramaniam NR; Srinivasalu VK; Balasubramanian D; Pushpaja KU; Nair AR; Prameela C; Thankappan K; Iyer S
    Indian J Cancer; 2017; 54(3):493-497. PubMed ID: 29798945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions.
    Withers HR; Peters LJ; Taylor JM; Owen JB; Morrison WH; Schultheiss TE; Keane T; O'Sullivan B; van Dyk J; Gupta N
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):549-62. PubMed ID: 7558943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative radiotherapy for squamous cell carcinoma of the maxillary sinus: analysis of local control and late complications.
    Ogawa K; Toita T; Kakinohana Y; Adachi G; Kojya S; Itokazu T; Shinhama A; Matsumura J; Murayama S
    Oncol Rep; 2001; 8(2):315-9. PubMed ID: 11182047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis.
    Rudoltz MS; Benammar A; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):767-72. PubMed ID: 8344844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brief report: prognostic importance of cellular DNA content in T1-2 N0 laryngeal squamous cell carcinomas treated with radiotherapy.
    Toffoli G; Franchin G; Barzan L; Cernigoi C; Carbone A; Sulfaro S; Franceschi S; Boiocchi M
    Laryngoscope; 1995 Jun; 105(6):649-52. PubMed ID: 7769952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
    Cho EI; Kowalski DP; Sasaki CT; Haffty BG
    Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Ann Otol Rhinol Laryngol; 2006 Oct; 115(10):727-32. PubMed ID: 17076093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.